IL2 and skin squamous cell carcinoma: Herein we demonstrate, for the first time to our knowledge, that an IL-2 based intra-lesional treatment strategy safely and effectively treated multiple high grade cSCC lesions in an immunocompromised, multi-organ transplant patient.